The use of mifepristone in the treatment of neuropsychiatric disordersDEBATTISTA, Charles; BELANOFF, Joseph.Trends in endocrinology and metabolism. 2006, Vol 17, Num 3, pp 117-121, issn 1043-2760, 5 p.Article

Nongenomic uterine relaxing effect of RU 486 (mifepristone) prior to its antiprogesterone activity in the human pregnancyPERUSQUIA, Mercedes; ESPINOZA, Julia; NAVARRETE, Erika et al.Steroids. 2009, Vol 74, Num 10-11, pp 825-831, issn 0039-128X, 7 p.Article

Levonorgestrel and mifepristone in emergency contraceptionVON HERTZEN, Helena; PIAGGIO, Gilda.Steroids. 2003, Vol 68, Num 10-13, pp 1107-1113, issn 0039-128X, 7 p.Conference Paper

Transvaginal ultrasound and the success of medical abortionEDELMAN, A; THOMAS, L; JENSEN, J et al.International journal of gynaecology and obstetrics. 2004, Vol 85, Num 1, pp 62-63, issn 0020-7292, 2 p.Article

Les antiprogestérones = AntiprogestinsSITRUK-WARE, R.La Presse médicale (1983). 1999, Vol 28, Num 38, pp 2123-2131, issn 0755-4982Article

Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathyZU HORSTE, Gerd Meyer; PRUKOP, Thomas; LIEBETANZ, David et al.Annals of neurology. 2007, Vol 61, Num 1, pp 61-72, issn 0364-5134, 12 p.Article

Mifepristone and misoprostol sequential regimen side effects, complications and safetySITRUK-WARE, Regine.Contraception (Stoneham). 2006, Vol 74, Num 1, pp 48-55, issn 0010-7824, 8 p.Article

Ob/Gyn training in abortion care: results from a national surveyJACKSON, Courtney B; FOSTER, Angel M.Contraception (Stoneham). 2012, Vol 86, Num 4, pp 407-412, issn 0010-7824, 6 p.Article

La contraception du futur: antiprogestatifs et vaccins = Contraception of the future: antiprogestins and vaccinesHUGON, J; FRANCIS, Z; CHABBERT-BUFFET, N et al.MT médecine de la reproduction gynécologie endocrinologie. 2009, Vol 11, Num 5-6, pp 372-377, 6 p.Article

Novel phosphorus-containing 17β-side chain mifepristone analogues as progesterone receptor antagonistsWEIQIN JIANG; ALLAN, George; LUNDEEN, Scott et al.Steroids. 2006, Vol 71, Num 11-12, pp 949-954, issn 0039-128X, 6 p.Article

Mifepristone may inhibit the midcycle gonadotropin surge at both ovarian and pituitary sites of actionHEIKINHEIMO, Oskari; LEMINEN, Riikka; RAIVIO, Taneli et al.Fertility and sterility. 2005, Vol 84, Num 5, pp 1545-1546, issn 0015-0282, 2 p.Article

Mifepristone: bioavailability, pharmacokinetics and use-effectivenessSARKAR, N. N.European journal of obstetrics, gynecology, and reproductive biology. 2002, Vol 101, Num 2, pp 113-120, issn 0301-2115Article

Mifepristone as a late post-coital contraceptiveASHOK, Premila W; WAGAARACHCHI, Prabhath T; FLETT, Gillian M et al.Human reproduction (Oxford. Print). 2001, Vol 16, Num 1, pp 72-75, issn 0268-1161Article

Mifepristone followed on the same day by vaginal misoprostol for early abortionPYMAR, Helen C; CREININ, Mitchell D; SCHWARTZ, Jill L et al.Contraception (Stoneham). 2001, Vol 64, Num 2, pp 87-92, issn 0010-7824Article

Fatal infections associated with mifepristone-induced abortionGREENE, Michael F.The New England journal of medicine. 2005, Vol 353, Num 22, pp 2317-2318, issn 0028-4793, 2 p.Article

Mifépristone et grossesse : Les faits maquants 2004 = Mifepristone and pregnancyLa Revue Prescrire. 2004, Vol 24, Num 255, pp 754-755, issn 0247-7750, 2 p.Conference Paper

11β-Substituted 13β-ethyl gonane derivatives exhibit reversal of antiprogestational activityRAO, P. N; CESSAC, J. W; BLYE, R. P et al.Steroids. 1998, Vol 63, Num 1, pp 50-57, issn 0039-128XArticle

Clinical pharmacokinetics of mifepristoneHEIKINHEIMO, O.Clinical pharmacokinetics. 1997, Vol 33, Num 1, pp 7-17, issn 0312-5963Article

Preclinical and Clinical Pharmacokinetics of PF-02413873, a Nonsteroidal Progesterone Receptor AntagonistBUNGAY, Peter J; TWEEDY, Sarah; HOWE, David C et al.Drug metabolism and disposition. 2011, Vol 39, Num 8, pp 1396-1405, issn 0090-9556, 10 p.Article

Effect of mifepristone on the expression of endometrial secretory leukocyte protease inhibitor in new medroxyprogesterone acetate usersAIMIN LI; FELIX, Juan C; WANGRONG YANG et al.Fertility and sterility. 2008, Vol 90, Num 3, pp 872-875, issn 0015-0282, 4 p.Article

Bifunctional gonadotropin-releasing hormone antagonist-progesterone analogs with increased efficacy and duration of actionRATCLIFFE, Karen E; FRASER, Hamish M; SELLAR, Robin et al.Endocrinology (Philadelphia). 2006, Vol 147, Num 1, pp 571-579, issn 0013-7227, 9 p.Article

Mifepristone and prostaglandin for termination of pregnancy : contraindications for use, reasons and rationaleDAVEY, Angela.Contraception (Stoneham). 2006, Vol 74, Num 1, pp 16-20, issn 0010-7824, 5 p.Article

Mifépristone à la dose de 100 mg dans les avortements médicamenteux = Mifepristone 100mg for early medical abortionJERBI, M; HIDAR, S; SAHRAOUI, W et al.Journal de gynécologie obstétrique et biologie de la reproduction. 2005, Vol 34, Num 3, pp 257-261, issn 0368-2315, 5 p., CAH1Article

Antiprogestatifs mécanisme d'action = Antiprogestins,mechanism of actionGUIOCHON-MANTEL, A.Reproduction humaine et hormones. 1999, Vol 12, Num 3, pp 248-253, issn 0994-3919Article

Can mifepristone medication abortion be successfully integrated into medical practices that do not offer surgical abortion?LEEMAN, Lawrence; ASARIA, Sheemain; ESPEY, Eve et al.Contraception (Stoneham). 2007, Vol 76, Num 2, pp 96-100, issn 0010-7824, 5 p.Article